Literature DB >> 35770098

The Invasive Species Reynoutria japonica Houtt. as a Promising Natural Agent for Cardiovascular and Digestive System Illness.

Shaoyang Liu1, Ruiyuan Zhang1, Xing Zhang1, Shun Zhu1, Siyu Liu1, Jue Yang1, Zhiping Li2, Tianhui Gao1, Fang Liu1, Huiling Hu1.   

Abstract

Polygoni Cuspidati Rhizoma et Radix, the dry roots and stems of Reynoutria japonica Houtt (called Huzhang, HZ in Chinese), is a traditional and popular chinese medicinal herb for thousands of years. As a widely used ethnomedicine in Asia including China, Japan, and Korea, HZ can invigorate the blood, cool heat, and resolve toxicity, which is commonly used in the treatment of favus, jaundice, scald, and constipation. However, HZ is now considered an invasive plant in the United States and many European countries. Therefore, in order to take advantage of HZ and solve the problem of biological invasion, scholars around the world have carried out abundant research studies on HZ. Until now, about 110 compounds have been isolated and identified from HZ, in which anthraquinones, stilbenes, and flavonoids would be the main bioactive ingredients for its pharmacological properties, such as microcirculation improvement, myocardial protective effects, endocrine regulation, anti-atherosclerotic activity, anti-oxidant activity, anti-tumor activity, anti-viral activity, and treatment of skin inflammation, burns, and scalds. HZ has a variety of active ingredients and broad pharmacological activities. It is widely used in health products, cosmetics, and even animal husbandry feed and has no obvious toxicity. Efforts should be made to develop more products such as effective drugs, health care products, cosmetics, and agricultural and animal husbandry products to benefit mankind.
Copyright © 2022 Liu, Zhang, Zhang, Zhu, Liu, Yang, Li, Gao, Liu and Hu.

Entities:  

Keywords:  Reynoutria japonica Houtt.; botany and ethnopharmacology; pharmacological activity; phytochemistry; quality control

Year:  2022        PMID: 35770098      PMCID: PMC9234309          DOI: 10.3389/fphar.2022.863707

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.988


  143 in total

Review 1.  Antioxidant and anti-inflammatory properties of the citrus flavonoids hesperidin and hesperetin: an updated review of their molecular mechanisms and experimental models.

Authors:  Hamideh Parhiz; Ali Roohbakhsh; Fatemeh Soltani; Ramin Rezaee; Mehrdad Iranshahi
Journal:  Phytother Res       Date:  2014-11-13       Impact factor: 5.878

2.  Polydatin promotes apoptosis through upregulation the ratio of Bax/Bcl-2 and inhibits proliferation by attenuating the β-catenin signaling in human osteosarcoma cells.

Authors:  Ge Xu; Ge Kuang; Wengao Jiang; Rong Jiang; Dianming Jiang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 3.  Genistein: Its role in metabolic diseases and cancer.

Authors:  Vidya Mukund; Dhruv Mukund; Vinay Sharma; Mastan Mannarapu; Afroz Alam
Journal:  Crit Rev Oncol Hematol       Date:  2017-09-12       Impact factor: 6.312

4.  Inhibition of phosphorylation of p38 MAPK involved in the protection of nephropathy by emodin in diabetic rats.

Authors:  Jinping Wang; Heqing Huang; Peiqing Liu; Futian Tang; Jia Qin; Wenge Huang; Fengying Chen; Fenfen Guo; Weihua Liu; Bing Yang
Journal:  Eur J Pharmacol       Date:  2006-09-14       Impact factor: 4.432

5.  Inhibitory effect of emodin and Astragalus polysaccharide on the replication of HBV.

Authors:  Shuang-Suo Dang; Xiao-Li Jia; Ping Song; Yan-An Cheng; Xin Zhang; Ming-Zhu Sun; En-Qi Liu
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

6.  Ataxia-telangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility.

Authors:  J Luis Espinoza; Akiyoshi Takami; Ly Q Trung; Shinji Nakao
Journal:  Cancer Sci       Date:  2013-04-26       Impact factor: 6.716

7.  Resveratrol supplementation improves metabolic control in rats with induced hyperlipidemia and type 2 diabetes.

Authors:  Aleksandar Rašković; Veljko Ćućuz; Ljilja Torović; Ana Tomas; Ljiljana Gojković-Bukarica; Tatjana Ćebović; Boris Milijašević; Nebojša Stilinović; Jelena Cvejić Hogervorst
Journal:  Saudi Pharm J       Date:  2019-08-30       Impact factor: 4.330

8.  Profiling of components of rhizoma et radix polygoni cuspidati by high-performance liquid chromatography with ultraviolet diode-array detector and ion trap/time-of-flight mass spectrometric detection.

Authors:  Jinfeng Fu; Min Wang; Huimin Guo; Yuan Tian; Zunjian Zhang; Rui Song
Journal:  Pharmacogn Mag       Date:  2015 Jul-Sep       Impact factor: 1.085

9.  A Natural Product from Polygonum cuspidatum Sieb. Et Zucc. Promotes Tat-Dependent HIV Latency Reversal through Triggering P-TEFb's Release from 7SK snRNP.

Authors:  Cong Wang; Shuiyuan Yang; Huasong Lu; Hongchao You; Man Ni; Wenjun Shan; Ting Lin; Xiang Gao; Haifeng Chen; Qiang Zhou; Yuhua Xue
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

10.  Physcion 8‑O‑β‑glucopyranoside extracted from Polygonum cuspidatum exhibits anti‑proliferative and anti‑inflammatory effects on MH7A rheumatoid arthritis‑derived fibroblast‑like synoviocytes through the TGF‑β/MAPK pathway.

Authors:  Qin Geng; Qiaofeng Wei; Shujun Wang; Huili Qi; Qin Zhu; Xia Liu; Xiaojun Shi; Shuyun Wen
Journal:  Int J Mol Med       Date:  2018-04-30       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.